Literature DB >> 8232717

Characterization of adenosine receptor-mediated generation of cyclic AMP in slices of rat cerebral cortex with chronic epileptic activity.

Y Hattori1, A Moriwaki, Y Hayashi, N Islam, Y Hori.   

Abstract

Cyclic AMP accumulations elicited by adenosine analogues 2-chloroadenosine (2-CADO), R-N6-phenylisopropyladenosine (R-PIA), and N6-cyclohexyladenosine (CHA) were investigated in cortical slices of chronic iron-induced epileptic rats. Cyclic AMP accumulation was elicited 9- to 18-fold by 2-CADO and it was elicited 5- to 7-fold by either R-PIA or CHA; 2-CADO was more potent than R-PIA or CHA in eliciting cyclic AMP accumulation. The adenosine analogues elicited cyclic AMP accumulation in a dose-dependent manner, and the elicitation was inhibited by the adenosine antagonist 8-phenyltheophylline. The 2-CADO-elicited accumulation of cyclic AMP was greatly increased in the cortical region on the primary epileptic side, while the R-PIA- or CHA-elicited accumulation did not change in any cortical region. The deviation detected only in the 2-CADO-elicited accumulation of cyclic AMP may be due to the difference in relative potency for adenosine receptors of the adenosine analogues. The results suggest that adenosine receptor-mediated generation of cyclic AMP is altered in the primary region of iron-induced epileptic cortex, in which heterogeneous alterations in different adenosine receptor subtypes may occur in the epileptic process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232717     DOI: 10.1007/bf00966761

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  29 in total

1.  Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.

Authors:  F W Smellie; C W Davis; J W Daly; J N Wells
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

2.  Regulation of cell growth by cyclic adenosine 3',5'-monophosphate. Effect of cell density and agents which alter cell growth on cyclic adenosine 3',5'-monophosphate levels in fibroblasts.

Authors:  J Otten; G S Johnson; I Pastan
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

3.  Epilepsy and cyclic nucleotides.

Authors:  J A Ferrendelli
Journal:  Adv Cyclic Nucleotide Res       Date:  1980

4.  An investigation of the low intrinsic activity of adenosine and its analogs at low affinity (A2) adenosine receptors in rat cerebral cortex.

Authors:  C W Bazil; K P Minneman
Journal:  J Neurochem       Date:  1986-08       Impact factor: 5.372

5.  Changes in seizure latency correlate with alterations in A1 adenosine receptor binding during daily repeated pentylentetrazol-induced convulsions in different mouse brain areas.

Authors:  F Angelatou; O Pagonopoulou; G Kostopoulos
Journal:  Neurosci Lett       Date:  1991-11-11       Impact factor: 3.046

6.  Development of epileptic activity induced by iron injection into rat cerebral cortex: electrographic and behavioral characteristics.

Authors:  A Moriwaki; Y Hattori; Y Hayashi; Y Hori
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1992-11

7.  In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection.

Authors:  W J Triggs; L J Willmore
Journal:  J Neurochem       Date:  1984-04       Impact factor: 5.372

8.  Enzymatic regulation of adenosine 3',5'-monophosphate (cyclic AMP) in the freezing epileptogenic lesion of rat brain and in homologous contralateral cortex.

Authors:  J E Walker; E Lewin; J R Sheppard; R Cromwell
Journal:  J Neurochem       Date:  1973-07       Impact factor: 5.372

9.  Activation of adenylate cyclase of rat brain by lipid peroxidation.

Authors:  A Baba; E Lee; A Ohta; T Tatsuno; H Iwata
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

10.  Formation of malonaldehyde and focal brain edema induced by subpial injection of FeCl2 into rat isocortex.

Authors:  L J Willmore; J J Rubin
Journal:  Brain Res       Date:  1982-08-19       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.